Disease/Infection News

RSS

Study tracks neurological symptoms in COVID-19 "long-haulers"

Researchers at University of California San Diego School of Medicine are conducting a longitudinal study to track neurological symptoms in COVID-19 "long-haulers."

16 Jun 2022

Vaccination provides good but temporary protection against SARS-CoV-2 omicron infection, study shows

A recent Pfizer or Moderna mRNA-vaccine booster provided good but temporary protection against infection by the SARS-CoV-2 omicron variant, according to a study from researchers at Weill Cornell Medicine—Qatar.

16 Jun 2022

Evidence COVID in pregnancy can affect offspring's neurodevelopment

In a recent study published in the Jama Network Open journal, researchers investigated the impact of in utero exposure to coronavirus disease 2019 (COVID-19) on the neurodevelopment of infants.

15 Jun 2022

Countries with female leaders recorded fewer COVID-19 deaths, study finds

Countries with female leaders recorded 40 per cent fewer COVID-19 deaths than nations governed by men, according to University of Queensland research.

15 Jun 2022

Scientists estimate the incubation period of 2022 monkeypox

In a recent study posted to the medRxiv* preprint server, researchers in the Netherlands estimated the incubation period for monkeypox.

15 Jun 2022

Fc-effector functions for selecting COVID-19 convalescent plasma

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that coronavirus disease 2019 (COVID-19) convalescent plasmas (CCPs) with low neutralizing and high fragment crystallizable (Fc)-effector activity result in effective prophylaxis.

15 Jun 2022

People with mental health problems at higher risk for severe COVID-19 outcomes

In a recent study published in the CDC’s Emerging Infectious Diseases journal, researchers assessed the associations between mental health conditions (MHCs) and severe outcomes of coronavirus disease 2019 (COVID-19).

15 Jun 2022

Two broadly neutralizing antibodies show promise to provide long-acting immunity against SARS-CoV-2

Two broadly neutralizing antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations according to a paper published June 15 in the Journal of Experimental Medicine (JEM).

15 Jun 2022

SARS-CoV-2 damages cilia

Researchers determine whether the interaction between ORF10 and ZYG11B promotes the dissemination of SARS-CoV-2.

15 Jun 2022

Treating anal precancerous growths reduces risk of anal cancer by more than half in HIV patients

A large clinical trial of people living with HIV has found that treating anal precancerous growths known as high-grade squamous intraepithelial lesions, or HSIL, reduces the chance that anal cancer will develop by more than half.

15 Jun 2022

More than 1,000 genes linked to severe COVID-19 identified

Since the start of the coronavirus pandemic, scientists and clinicians have struggled to understand why some people with the infection become seriously ill or die while others have few, if any, symptoms.

15 Jun 2022

Survey data provides insights into how many students are experiencing long COVID

New data from the School Infection Survey (SIS) showed that 1.8% of primary school pupils and 4.8% of secondary school pupils experienced long COVID following their most recent COVID-19 infection (since March 2020).

15 Jun 2022

Will the US overcome its covid complacency even as the threat returns?

A few months ago, it seemed as though the country was poised to finally tame the pandemic, after two years of restrictions and tens of billions in government spending.

15 Jun 2022

Global study yields new insights into the effectiveness of social distancing messaging

A massive, global study of social distancing motivations has yielded new, psychology-based insights into the effectiveness of different styles of social distancing messaging.

15 Jun 2022

Scientists characterize type I IFN response during SARS-CoV-2 infection

In a recent study posted to the bioRxiv* preprint server, Canadian researchers assessed the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on interferon (IFN) response.

15 Jun 2022

Study describes how coronavirus subverts a host cell pathway to infect human cells

An international team of scientists, led by the University of Bristol, has been investigating how the SARS-CoV-2 virus, the coronavirus responsible for the COVID-19 pandemic, manipulates host proteins to penetrate into human cells.

15 Jun 2022

Study reveals the dynamics of disease recovery after severe COVID-19

Recovery from severe COVID-19 is characterized by a reduction of certain white blood cells and changes in the molecular regulation of the immune system.

15 Jun 2022

New test can tell if you are immune to SARS-CoV-2

In a recent study published in the journal Nature Biotechnology, an international team of researchers developed and evaluated quantitative polymerase chain reaction (qPCR)-based assays to quantify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific functional T cell immunity.

15 Jun 2022

Medicare for all in the U.S. could have saved over 338,000 lives during COVID pandemic

In a recent study published in the journal PNAS, researchers propose a single-payer universal healthcare system in the United States (US) as a pandemic preparedness measure.

15 Jun 2022

Scotland's monitoring program for SARS-CoV-2 in wastewater

In a recent study, researchers reported on the use of the wastewater-based epidemiology (WBE) approach to evaluate the levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) shed into the Scottish sewage network.

14 Jun 2022

Disease/Infection News

Study tracks neurological symptoms in COVID-19 "long-haulers"

Vaccination provides good but temporary protection against SARS-CoV-2 omicron infection, study shows

Evidence COVID in pregnancy can affect offspring's neurodevelopment

Countries with female leaders recorded fewer COVID-19 deaths, study finds

Scientists estimate the incubation period of 2022 monkeypox

Fc-effector functions for selecting COVID-19 convalescent plasma

People with mental health problems at higher risk for severe COVID-19 outcomes

Two broadly neutralizing antibodies show promise to provide long-acting immunity against SARS-CoV-2

SARS-CoV-2 damages cilia

Treating anal precancerous growths reduces risk of anal cancer by more than half in HIV patients

More than 1,000 genes linked to severe COVID-19 identified

Survey data provides insights into how many students are experiencing long COVID

Will the US overcome its covid complacency even as the threat returns?

Global study yields new insights into the effectiveness of social distancing messaging

Scientists characterize type I IFN response during SARS-CoV-2 infection

Study describes how coronavirus subverts a host cell pathway to infect human cells

Study reveals the dynamics of disease recovery after severe COVID-19

New test can tell if you are immune to SARS-CoV-2

Medicare for all in the U.S. could have saved over 338,000 lives during COVID pandemic

Scotland's monitoring program for SARS-CoV-2 in wastewater

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News